Prevision of multidisciplinary head and neck cancer survivorship care during the 2019 novel coronavirus pandemic

The 2019 Coronavirus Pandemic challenges the delivery of care for patients with head and neck cancer. An important aspect of this care has been the evolution of enhanced survivorship services, which include surveillance for recurring cancer and prevention of second primaries. The application of evid...

Full description

Saved in:
Bibliographic Details
Published in:Head & Neck 2020-07, Vol.42 (7), p.1668-1673
Main Authors: Nilsen, Marci Lee, Clump, David A., Kubik, Mark, Losego, Karen, Mrozek, Alyssa, Pawlowicz, Elizabeth, Pickford, Debra, Sridharan, Shaum, Traylor, Katie, Wasserman‐Wincko, Tamara, Young, Kelly, Zandberg, Dan, Johnson, Jonas T.
Format: Article
Language:English
Subjects:
Betacoronavirus
cancer
Chemoradiotherapy
Continuity of Patient Care - organization & administration
coronavirus
Coronavirus Infections - epidemiology
Coronaviruses
COVID-19
Deglutition Disorders - etiology
Deglutition Disorders - rehabilitation
Dental Care
Diagnostic Imaging
Head & neck cancer
head and neck
Head and Neck Neoplasms - therapy
Humans
Infection Control
Infectious Disease Transmission, Patient-to-Professional - prevention & control
Nutrition Assessment
Occupational Exposure - prevention & control
Pandemics
Patient Care Team
Patient Reported Outcome Measures
Pennsylvania - epidemiology
Personal Protective Equipment
Physical Examination
Physical Therapy Modalities
Pneumonia, Viral - epidemiology
Quality Assurance, Health Care
Quality of Life
SARS-CoV-2
Special Issue
Speech Therapy
Surveys and Questionnaires
Survival
Survivorship
Suvivorship
Symptom Assessment
Telemedicine
treatment effects
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The 2019 Coronavirus Pandemic challenges the delivery of care for patients with head and neck cancer. An important aspect of this care has been the evolution of enhanced survivorship services, which include surveillance for recurring cancer and prevention of second primaries. The application of evidence‐based approaches to the identification and management of treatment and tumor‐related toxicities has embraced the use of validated patient‐reported outcomes instruments, health promotion, and care coordination. In this manuscript, we describe how our multidisciplinary team of survivorship providers has accommodated to the need to provide patients with social distancing while acknowledging the importance of continued care during treatment and through the spectrum of survivorship.
ISSN:1043-3074
1097-0347
DOI:10.1002/hed.26256